Zhongjin Irradiation Incorporated Company provides irradiation services in China. More Details
Excellent balance sheet with questionable track record.
Share Price & News
How has Zhongjin Irradiation's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: Insufficient data to determine 300962's volatility over the past 3 months.
Volatility Over Time: Insufficient data to determine 300962's volatility change over the past year.
7 Day Return
CN Life Sciences
1 Year Return
CN Life Sciences
Return vs Industry: Insufficient data to determine how 300962 performed against the CN Life Sciences industry.
Return vs Market: Insufficient data to determine how 300962 performed against the CN Market.
Long-Term Price Volatility Vs. Market
How volatile is Zhongjin Irradiation's share price compared to the market and industry in the last 5 years?
Simply Wall St News
No news available
Is Zhongjin Irradiation undervalued compared to its fair value and its price relative to the market?
Price to Earnings (PE) ratio
Share Price vs. Fair Value
Below Fair Value: 300962 (CN¥26.48) is trading above our estimate of fair value (CN¥18.38)
Significantly Below Fair Value: 300962 is trading above our estimate of fair value.
Price To Earnings Ratio
PE vs Industry: 300962 is poor value based on its PE Ratio (70.2x) compared to the CN Life Sciences industry average (66.8x).
PE vs Market: 300962 is poor value based on its PE Ratio (70.2x) compared to the CN market (30.7x).
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate 300962's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: 300962 is overvalued based on its PB Ratio (8.5x) compared to the CN Life Sciences industry average (7.6x).
How is Zhongjin Irradiation forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
Forecasted Pharmaceuticals & Biotech industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Zhongjin Irradiation has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
How has Zhongjin Irradiation performed over the past 5 years?
Last years earnings growth
Earnings and Revenue History
Quality Earnings: 300962 has high quality earnings.
Growing Profit Margin: 300962's current net profit margins (29%) are higher than last year (23.3%).
Past Earnings Growth Analysis
Earnings Trend: Unable to establish if 300962's year-on-year earnings growth rate was positive over the past 5 years as it has been trading publicly for less than 3 years.
Accelerating Growth: Unable to compare 300962's past year earnings growth to its 5-year average as it has been trading publicly for less than 3 years.
Earnings vs Industry: 300962 earnings growth over the past year (38.4%) underperformed the Life Sciences industry 109.6%.
Return on Equity
High ROE: 300962's Return on Equity (9.7%) is considered low.
How is Zhongjin Irradiation's financial position?
Financial Position Analysis
Short Term Liabilities: 300962's short term assets (CN¥306.1M) exceed its short term liabilities (CN¥54.9M).
Long Term Liabilities: 300962's short term assets (CN¥306.1M) exceed its long term liabilities (CN¥54.0M).
Debt to Equity History and Analysis
Debt Level: 300962's debt to equity ratio (3.5%) is considered satisfactory.
Reducing Debt: Insufficient data to determine if 300962's debt to equity ratio has reduced over the past 5 years.
Debt Coverage: 300962's debt is well covered by operating cash flow (537.3%).
Interest Coverage: 300962's interest payments on its debt are well covered by EBIT (31x coverage).
What is Zhongjin Irradiation current dividend yield, its reliability and sustainability?
Current Dividend Yield
Dividend Yield vs Market
Notable Dividend: 300962's dividend (0.6%) is higher than the bottom 25% of dividend payers in the CN market (0.47%).
High Dividend: 300962's dividend (0.6%) is low compared to the top 25% of dividend payers in the CN market (1.86%).
Stability and Growth of Payments
Stable Dividend: Too early to tell whether 300962's dividend payments have been stable as they only just started paying a dividend.
Growing Dividend: Too early to tell if 300962's dividend payments are increasing as they only just started paying a dividend.
Current Payout to Shareholders
Dividend Coverage: With its reasonably low payout ratio (42.4%), 300962's dividend payments are well covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: Insufficient data to determine if a dividend will be paid in 3 years and that it will be covered by earnings.
How experienced are the management team and are they aligned to shareholders interests?
Zhongjin Irradiation has no CEO, or we have no data on them.
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Dilution of Shares: 300962 only recently listed within the past 12 months.
Zhongjin Irradiation Incorporated Company's company bio, employee growth, exchange listings and data sources
- Name: Zhongjin Irradiation Incorporated Company
- Ticker: 300962
- Exchange: SZSE
- Founded: 2003
- Industry: Life Sciences Tools and Services
- Sector: Pharmaceuticals & Biotech
- Market Cap: CN¥6.645b
- Shares outstanding: 264.00m
- Website: https://www.zjfzgroup.com
Number of Employees
- Zhongjin Irradiation Incorporated Company
- China Dongsheng Road 68
- Luohu District
- Guangdong Province
Zhongjin Irradiation Incorporated Company provides irradiation services in China. It offers radiation processing services, such as medical product sterilization, food preservation, chemical materials modif...
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2021/05/17 09:47|
|End of Day Share Price||2021/05/17 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.